AIG
BLPH

American International Group’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

American International Group’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,614
Closed -$14 – 3412
2021
Q1 		$14 Buy
2,614
+6
+0.2% +$42 ﹤0.01% 3149
2020
Q4 		$17 Sell
2,608
-74
-3% -$606 ﹤0.01% 3102
2020
Q3 		$27K Buy
2,682
+577
+27% +$6.79K ﹤0.01% 3017
2020
Q2 		$26K Buy
+2,105
New +$29.5K ﹤0.01% 3021

Other funds holding BLPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

American International Group's BLPH Position: Q2 2021 in Review

American International Group sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q2 2021, closing a stake of 2,614 shares — an estimated $14 sold.

American International Group first reported a position in BLPH in Q2 2020 and held it in 4 quarters. The position peaked at $27K in Q3 2020. 27 funds tracked by Wall St. Rank hold BLPH as of Q2 2021.

  • American International Group reported no remaining Bellerophon Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 2,614 Bellerophon Therapeutics, Inc. shares in Q2 2021, an estimated $14.
  • American International Group first reported a position in Bellerophon Therapeutics, Inc. in Q2 2020 and held it in 4 quarters.
  • American International Group's Bellerophon Therapeutics, Inc. position peaked at $27K in Q3 2020.
  • 27 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.